Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation

BACKGROUND/AIMS: The most commonly used immunosuppressant therapy after liver transplantation (LT) is a combination of tacrolimus and steroid. Basiliximab induction has recently been introduced; however, the most appropriate immunosuppression for hepatocellular carcinoma (HCC) patients after LT is s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lee, Ju-Yeun, Kim, Yul Hee, Yi, Nam-Joon, Kim, Hyang Sook, Lee, Hye Suk, Lee, Byung Koo, Kim, Hyeyoung, Choi, Young Rok, Hong, Geun, Lee, Kwang-Woong, Suh, Kyung-Suk
Format: Artigo
Sprache:Inglês
Veröffentlicht: The Korean Association for the Study of the Liver 2014
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4099335/
https://ncbi.nlm.nih.gov/pubmed/25032186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2014.20.2.192
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge